Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Verrotti

Showing results (131-140 of 446) with videos related to

Pageof 45
Sort By:
Expert Review of Neurotherapeutics|June 21, 2006
The treatment of juvenile myoclonic epilepsyAlberto Verrotti, Rossella Manco, Giovanna di Marco, et al.
International Journal of Environmental Research and Public Health|July 2, 2021
New Onset of Hepatic Steatosis Post-Severe Multisystem Inflammatory Syndrome in Children (MIS-C): A Case ReportRossella Sica, Serena Pennoni, Laura Penta, et al.
Seizure|February 23, 2013
What have we learned about ictal epileptic headache? A review of well-documented casesPasquale Parisi, Pasquale Striano, Alberto Verrotti, et al.
The Lancet. Child & Adolescent Health|August 19, 2018
Near infrared investigation of the infants' brainAntonio M Chiarelli, Alberto Verrotti, Massimo Caulo, et al.
Expert Opinion on Pharmacotherapy|February 21, 2020
What are the challenges with the pharmacological management of epilepsy in patients with Attention Deficit Hyperactivity Disorder (ADHD)?Sara Matricardi, Giovanni Farello, Francesca Felicia Operto, et al.
CNS Drugs|September 3, 2020
Fenfluramine for the Treatment of Dravet Syndrome and Lennox-Gastaut SyndromeGanna Balagura, Marta Cacciatore, Eleonora A Grasso, et al.
Brain and Cognition|December 24, 2013
Memory impairment and Benign Epilepsy with centrotemporal spike (BECTS): a growing suspicionAlberto Verrotti, Melissa Filippini, Sara Matricardi, et al.
Epilepsia|January 6, 2011
Antiepileptic drugs, sex hormones, and PCOSAlberto Verrotti, Claudia D'Egidio, Angelika Mohn, et al.
Core Evidence|March 23, 2018
Eslicarbazepine acetate in the treatment of adults with partial-onset epilepsy: an evidence-based review of efficacy, safety and place in therapySimona Lattanzi, Francesco Brigo, Claudia Cagnetti, et al.
Human Mutation|August 8, 2015
A New Homozygous IGF1R Variant Defines a Clinically Recognizable Incomplete Dominant form of SHORT SyndromePaolo Prontera, Lucia Micale, Alberto Verrotti, et al.
Pageof 45

Showing results (131-140 of 446) with videos related to

Sort By:
Pageof 45
Expert Review of Neurotherapeutics|June 21, 2006
The treatment of juvenile myoclonic epilepsyAlberto Verrotti, Rossella Manco, Giovanna di Marco, et al.
International Journal of Environmental Research and Public Health|July 2, 2021
New Onset of Hepatic Steatosis Post-Severe Multisystem Inflammatory Syndrome in Children (MIS-C): A Case ReportRossella Sica, Serena Pennoni, Laura Penta, et al.
Seizure|February 23, 2013
What have we learned about ictal epileptic headache? A review of well-documented casesPasquale Parisi, Pasquale Striano, Alberto Verrotti, et al.
The Lancet. Child & Adolescent Health|August 19, 2018
Near infrared investigation of the infants' brainAntonio M Chiarelli, Alberto Verrotti, Massimo Caulo, et al.
Expert Opinion on Pharmacotherapy|February 21, 2020
What are the challenges with the pharmacological management of epilepsy in patients with Attention Deficit Hyperactivity Disorder (ADHD)?Sara Matricardi, Giovanni Farello, Francesca Felicia Operto, et al.
CNS Drugs|September 3, 2020
Fenfluramine for the Treatment of Dravet Syndrome and Lennox-Gastaut SyndromeGanna Balagura, Marta Cacciatore, Eleonora A Grasso, et al.
Brain and Cognition|December 24, 2013
Memory impairment and Benign Epilepsy with centrotemporal spike (BECTS): a growing suspicionAlberto Verrotti, Melissa Filippini, Sara Matricardi, et al.
Epilepsia|January 6, 2011
Antiepileptic drugs, sex hormones, and PCOSAlberto Verrotti, Claudia D'Egidio, Angelika Mohn, et al.
Core Evidence|March 23, 2018
Eslicarbazepine acetate in the treatment of adults with partial-onset epilepsy: an evidence-based review of efficacy, safety and place in therapySimona Lattanzi, Francesco Brigo, Claudia Cagnetti, et al.
Human Mutation|August 8, 2015
A New Homozygous IGF1R Variant Defines a Clinically Recognizable Incomplete Dominant form of SHORT SyndromePaolo Prontera, Lucia Micale, Alberto Verrotti, et al.
Pageof 45